Description
This course delves into the complex interplay between immune-mediated inflammatory diseases (IMIDs) and cardiovascular disease, exploring the intricate relationships between them. Participants will gain a deep understanding of how IMIDs affect lipid levels, including the intriguing concept of the lipid paradox. The course further examines the multifaceted impact of HMG-CoA reductase inhibitors, commonly known as ‘statins,’ on IMIDs, encompassing both lipid-related and non-lipid-related mechanisms. Additionally, participants will delve into the comprehensive landscape of statin side effects, covering their rates, predisposing factors, and effective management strategies. Through this course, participants will enhance their knowledge and proficiency in managing IMIDs and related cardiovascular complications, equipping them with valuable insights to optimize patient care and outcomes.
LEARNING OBJECTIVES
- Review the relationships between immune-mediated inflammatory disease (IMIDs aka inflammatory autoimmune conditions) and cardiovascular disease.
- Understand the effect of these conditions on lipid levels in particular (e.g. lipid paradox).
- Differentiate multiple ways HMG-CoA reductase inhibitors (aka ‘statins’) can impact IMIDs via both lipid and non-lipid-related mechanisms.
- Define statin side effects including rates, predisposing factors, and management strategies.
Approved for 1.5 Cat A Credits in Pharmacology (CONO) & 1.5 Cat F Credits (CNPBC)
Title: The Lipid Paradox: Relationship Between Immune-mediated Inflammatory Disease & Cardiovascular
Speaker: Dr. Alexandra Verge ND
Price: $49.99 CAD
